Cargando…
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up
BACKGROUND: Efficacious immune-based therapy in treated chronic HIV-1 infection requires the induction of virus-specific CD4(+ )T cells and subsequent maturation and maintenance of specific memory CD8(+ )T cells. Concomitant daily administration of recombinant human growth hormone (rhGH) with highly...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613878/ https://www.ncbi.nlm.nih.gov/pubmed/18976455 http://dx.doi.org/10.1186/1476-8518-6-7 |